MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
---|---|---|
New | Abrilada | |
New | Abrysvo | |
New | APOHealth Picosulfate Prep | |
New | Azacitidine Dr. Reddy's | |
New | Blooms the Chemist Quetiapine | |
New | CeeNU (BMS Canada) | |
New | Chemists' Own Picosulfate Prep | |
New | Clavulin-125F (Canada) | |
New | Coloxyl Macrogol for Children | |
New | Differin Acne Treatment | |
New | Gonadron | |
New | Jemperli (GSK, UK) | |
New | Klaciped Forte (Switzerland) | |
New | Koselugo | |
New | Nuceiva | |
New | Onpattro | |
New | Orencia (Germany) (Link) | |
New | Paracetamol S.A.L.F. (Israel) | |
New | Parecoxib Medsurge | |
New | Phenylephrine Baxter | |
New | SalplusF DPI 250/50 | |
New | SalplusF DPI 500/50 | |
New | Sevredol (Napp Pharmaceuticals, UK) | |
New | Sitagliptin Mylan | |
New | Sitagliptin/Metformin Mylan | |
New | Stemetil (Singapore) | |
New | Vorcon | |
New | Zithromax (South Korea) | |
Reinstated | Oxycodone BNM | |
Revised | Aeris Medical E.P. Grade Compressed Oxygen | Nature and Contents of Container |
Revised | Air Liquide Australia Limited Medical Oxygen | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Air Liquide Australia Limited Oxygen Bulk Liquid | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Ajovy | Adverse Effects (Undesirable Effects) |
Revised | Albey Venom | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Overdose, Pharmaceutical Form, Pharmacological Properties, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Amantamed | TGA Date |
Revised | Amiloxyn | Sponsor |
Revised | Amoxicillin/Clavulanic Acid Viatris | Adverse Effects (Undesirable Effects) |
Revised | Amphotericin Liposomal SUN | TGA Date |
Revised | APO-Amoxy/Clav | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | APO-Clindamycin | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | APO-Fentanyl | Special Warnings and Precautions for Use |
Revised | APO-Fluconazole (was Fluconazole APOTEX) | Product Name change |
Revised | APO-Rizatriptan ODT (was Rizatriptan ODT Apotex) | Product Name change |
Revised | APX-Amoxicillin/Clavulanic Acid | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Sponsor |
Revised | APX-Ondansetron | Sponsor |
Revised | APX-Ondansetron ODT | Sponsor |
Revised | Arthrexin | Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Qualitative and Quantitative Composition |
Revised | Atacand | Sponsor |
Revised | Atacand Plus | Sponsor |
Revised | Axit | Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Azacitidine Juno | Adverse Effects (Undesirable Effects) |
Revised | Bacthecal | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Bavencio | Special Warnings and Precautions for Use |
Revised | Beovu | Adverse Effects (Undesirable Effects) |
Revised | Bi Eligard cp | Dose and Method of Administration, Nature and Contents of Container, Pharmaceutical Form |
Revised | Bicor | Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Bispro | List of Excipients, Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Blooms the Chemist Amoxicillin/Clavulanic Acid 875/125 | Adverse Effects (Undesirable Effects) |
Revised | Bosentan Dr. Reddy's | Fertility, Pregnancy and Lactation |
Revised | Calindamin | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | Ceclor CD | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Cefaclor Sun | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Cerezyme | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Chemists' Own Clozole 1% Vaginal Cream | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Chemists' Own Coldeze Tablets | TGA Date |
Revised | Ciprol | Sponsor |
Revised | Clindamycin Lu | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Clindamyk | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | Clofen | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Clopine | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | Comirnaty (Tris/Sucrose Presentation) | Adverse Effects (Undesirable Effects) |
Revised | Comirnaty Omicron XBB.1.5 | Adverse Effects (Undesirable Effects) |
Revised | Comirnaty Original/Omicron BA.4-5 | Adverse Effects (Undesirable Effects) |
Revised | Cosdor | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Creon Micro | Qualitative and Quantitative Composition |
Revised | Crestor | Adverse Effects (Undesirable Effects) |
Revised | Curam 125/31.25 Powder for Suspension | Adverse Effects (Undesirable Effects) |
Revised | Curam Duo 400/57 Powder for Suspension | Adverse Effects (Undesirable Effects) |
Revised | Curam Duo 500/125 and Curam Duo Forte 875/125 Tablets | Adverse Effects (Undesirable Effects) |
Revised | Curam Powder for injection | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Cyproterone Sandoz | TGA Date |
Revised | Cyproterone Sandoz 50 mg | TGA Date |
Revised | Denpax | Special Warnings and Precautions for Use |
Revised | Dexamethasone Medsurge | Fertility, Pregnancy and Lactation, Overdose, Special Warnings and Precautions for Use |
Revised | Diphereline | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Dymista 125/50 | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Elaxine SR | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Eligard | Dose and Method of Administration, Nature and Contents of Container, Pharmaceutical Form |
Revised | Erlyand | Special Warnings and Precautions for Use |
Revised | Etopophos | Adverse Effects (Undesirable Effects) |
Revised | Eylea | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, List of Excipients, Nature and Contents of Container, Overdose, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Femolet | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Fenofibrate RBX | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Fentanyl Sandoz | Special Warnings and Precautions for Use |
Revised | Flucil | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions |
Revised | Flucil Oral Liquid | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions |
Revised | Fludara Oral | Nature and Contents of Container |
Revised | Flutamin | Special Precautions for Storage |
Revised | FML | Shelf Life, Special Precautions for Storage |
Revised | Gardasil 9 | Nature and Contents of Container |
Revised | Glucovance | Qualitative and Quantitative Composition |
Revised | Glyceryl Trinitrate Medsurge | TGA Date |
Revised | Ibrance | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Imigran Migraine | Pharmacological Properties |
Revised | Imovane | Special Warnings and Precautions for Use |
Revised | Inza | Qualitative and Quantitative Composition |
Revised | Isturisa | Adverse Effects (Undesirable Effects) |
Revised | Itracap | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties |
Revised | Itranox | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties |
Revised | Kalixocin | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Ketoral Injection | Qualitative and Quantitative Composition |
Revised | Keytruda | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Therapeutic Indications |
Revised | Kimmtrak | Adverse Effects (Undesirable Effects), Pharmacological Properties |
Revised | Klacid | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Libtayo | Sponsor |
Revised | Liposomal Doxorubicin SUN | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Lurasidone Lupin | Physicochemical Properties, Qualitative and Quantitative Composition |
Revised | Luveris | Dose and Method of Administration, Pharmacological Properties |
Revised | Maxigesic IV | Adverse Effects (Undesirable Effects), Overdose, Special Warnings and Precautions for Use |
Revised | Melatonin MR-Teva | Pharmaceutical Form |
Revised | MenQuadfi | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Meropenem Juno | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Metoprolol Sandoz | TGA Date |
Revised | Mirena | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Mitozantrone Ebewe | Qualitative and Quantitative Composition |
Revised | M-M-R II | TGA Date |
Revised | Morphine Juno | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | Morphine Sulfate Medsurge | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | Myleran | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Myoview | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Nerlynx | TGA Date |
Revised | Nexviazyme | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Ogivri | Sponsor |
Revised | Pharmacor Tacrolimus | Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties |
Revised | PiperTaz Sandoz | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Presolol | Nature and Contents of Container, Special Precautions for Storage |
Revised | ProQuad | TGA Date |
Revised | Qinlock | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Quinate | Sponsor |
Revised | Rabeprazole Sun | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Ramipril Sandoz 10 mg Capsules | Nature and Contents of Container |
Revised | Repatha | Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Sandostatin | Special Warnings and Precautions for Use |
Revised | Sandostatin LAR | Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Sandoz Venlafaxine XR | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Saphnelo | Adverse Effects (Undesirable Effects) |
Revised | Septrin Forte | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Sotyktu | Physicochemical Properties |
Revised | Spikevax | Adverse Effects (Undesirable Effects) |
Revised | Spikevax Bivalent Original/Omicron BA.4-5 | Adverse Effects (Undesirable Effects) |
Revised | Spiolto Respimat (with dose indicator) | Nature and Contents of Container |
Revised | Spravato | Adverse Effects (Undesirable Effects) |
Revised | Stildem | Pharmaceutical Form |
Revised | Syquet | TGA Date |
Revised | Tacrograf | Interactions with Other Medicines and Other Forms of Interactions, Sponsor |
Revised | Tazopip | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Tobramycin Sun | Special Warnings and Precautions for Use |
Revised | Trajenta | Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Trajentamet | Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Trikafta | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Trodelvy | TGA Date |
Revised | Urex Forte | Product Name change, Qualitative and Quantitative Composition |
Revised | Veklury Powder for Injection | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Vfend | Dose and Method of Administration |
Revised | Voxzogo | Adverse Effects (Undesirable Effects) |
Revised | Vyvanse | Shelf Life |
Revised | Xevudy | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Overdose, Pharmacological Properties |
Revised | Zeldox IM | List of Excipients, Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Zinnat | Adverse Effects (Undesirable Effects) |
Revised | Zoloft | Nature and Contents of Container, Pharmaceutical Form |
Revised | Zotren | Sponsor |
Revised | Zotren ODT | Sponsor |
Deleted | Baraclude | |
Deleted | Bosentan Cipla | |
Deleted | Champix | |
Deleted | Clindamycin BNM | |
Deleted | Hydralazine Hydrochloride Tablets USP (Camber, USA) | |
Deleted | Keforal Oral Suspension (Italy) | |
Deleted | Rizatriptan ODT GH | |
Deleted | Ronapreve | |
Deleted | Roximycin | |
Deleted | Shingrix (GSK, Hong Kong) | |
Deleted | Shingrix (GSK, NZ) | |
Deleted | Shingrix (GSK, USA) | |
Deleted | Suxamethonium Chloride Injection (Mercury Pharma) | |
Deleted | Tarceva | |
Deleted | Vyvanse (USA) | |
Deleted | Zostavax |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Suite 1602, Level 16
44 Market Street
Sydney NSW 2000
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au